Close

Spectrum Pharmaceuticals, Inc. (SPPI) Easily Tops Q3 EPS Views

October 28, 2011 7:01 AM EDT
Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) reported Q3 EPS of $0.34, $0.24 better than the analyst estimate of $0.10. Revenue for the quarter came in at $51.02 million versus the consensus estimate of $40.17 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings